文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

巴基斯坦注射吸毒人群中值得关注的传播性HIV耐药

Notable transmitted HIV drug resistance among people who inject drugs in Pakistan.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

该横断面研究在巴基斯坦五个城市招募注射吸毒者,对282份HIV阳性干血斑标本进行pol基因测序,发现63.8%参与者携带至少一种耐药突变,99.4%未接受抗病毒治疗,88.7%从未检测HIV,提示该人群传播性耐药严重且检测与治疗覆盖不足。

要点

  • 注射吸毒者中63.8%携带至少一种HIV耐药突变。
  • 99.4%未接受ART,88.7%从未检测HIV且不知情。
  • 28.9%携带耐药突变者曾使用专业注射者帮助注射。

核心结论

  • 巴基斯坦注射吸毒人群中传播性HIV耐药显著,不安全注射尤其是专业注射加剧传播。
  • 低检测率提示需扩大检测项目以提高HIV状态知晓率和ART覆盖率。

研究设计与样本

  • 从282份HIV阳性干血斑标本中扩增HIV pol基因,用in-house Sanger测序进行耐药突变基因分型,参照斯坦福大学HIV耐药数据库识别突变。

主要发现

  • HIV亚型以A1为主(78.0%,n=220),其次为CRF02_AG(15.6%,n=44)、重组体(3.5%,n=10)、CRF35_AD(2.5%,n=7)和C亚型(0.4%,n=1)。
  • 63.8%参与者携带至少一种耐药突变,其中28.9%报告使用专业注射者帮助。
  • 99.4%未积极接受ART,88.7%从未检测HIV且不知晓自身状态。

临床怎么用

  • 应加强注射吸毒人群的HIV检测覆盖,以发现感染者并提高ART覆盖率。
  • 需关注不安全注射行为,特别是专业注射者相关的传播风险。
  • 在资源有限地区应扩大基因型耐药检测可及性以指导治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transmission of drug-resistant HIV strains to treatment-naïve patients can compromise antiretroviral therapy (ART) effectiveness and lead to treatment failure. In Pakistan, transmitted HIV drug resistance among people who inject drugs (PWID) is fuelled by a lack of harm reduction, ART, poor drug adherence, and unsafe injection practices, resulting in efficient transmission in large injecting networks. METHODS: A cross-sectional study was conducted among PWID recruited in Karachi, Larkana, Peshawar, Quetta and Hyderabad (August to December 2014). A portion of the HIV pol gene was amplified from HIV-reactive dried blood spot specimens (n = 282/367) and sequenced using an in-house Sanger sequencing assay for HIV drug resistance mutation (DRM) genotyping. DRMs were identified using the Stanford University HIV Drug Resistance Database (https://hivdb.stanford.edu/hivdb). RESULTS: Overall, HIV subtype A1 was dominant (78.0%; n = 220), followed by CRF02_AG (15.6%; n = 44), CRF35_AD (2.5% n = 7), recombinants (3.5%; n = 10), and subtype C (0.4% n = 1). DRM analysis identified that over half (63.8%) of participants harboured at least one DRM, of which 28.9% reported using help from a professional injector. Nearly all (99.4%) participants were not actively receiving ART because most (88.7%) had never undergone HIV testing and were unaware of their status. CONCLUSIONS: Findings suggest significant transmitted HIV drug resistance present among PWID, exacerbated by unsafe injection practices, particularly professional injection. Low testing rates signal a need for more comprehensive testing programs to improve HIV status awareness and ART coverage in Pakistan. These gaps remain especially urgent given persistent challenges in the national response, including low ART coverage, poor adherence, and limited access to genotypic resistance testing.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Melnychuk S, Thompson LH, Archibald C, et al. Notable transmitted HIV drug resistance among people who inject drugs in Pakistan. J Antimicrob Chemother. 2026. PMID: 41217897. doi:10.1093/jac/dkaf425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。